Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:2/19/2019)... , ... February 19, 2019 , ... ... Release Weight, Create Health, Wealth and Have the Life You Want!” (published by ... those challenged with weight issues to release the pounds, reconnect to their dreams ...
(Date:2/19/2019)... ... , ... The San Diego Superior Court has entered a judgment approving the ... of a class of approximately 14,100 patients who were admitted in-patient to one of ... 2013, in a class action case (Santana, et al. v. Rady Children’s Hospital – ...
(Date:2/16/2019)... ... 15, 2019 , ... SilcSkin – silicone anti-wrinkle pad pioneer and creator of ... Product for 2019 in the Neck and Decolleté category for the second time. The ... attendees of the International Congress of Esthetics and Spa. Developed by two-time Emmy award ...
(Date:2/14/2019)... (PRWEB) , ... February 14, 2019 , ... ... completed the purchase of Lydia’s Uniforms’ (“Lydia’s”) assets, including the Tafford and Lydia ... shoes and supplies to healthcare professionals for more than 40 years. , Lydia’s ...
(Date:2/14/2019)... ... February 14, 2019 , ... ... support which will directly impact Spaulding’s programs and services. , “The generous support ... organization and in the lives of the children we serve for years to ...
Breaking Medicine News(10 mins):
... 27 454 Life Sciences, a Roche,company, today ... the company,s Genome Sequencer(TM) FLX system to sequence ... The study,entitled "Whole-Genome Shotgun Sequencing of Mitochondria from ... in the journal Science. The study describes ...
... is a moron in the morning and a genius in ... were discovered by a new study performed by Vanderbilt University ... the National Academy of Sciences., This is the first example ... its biological clock, says Terry L. Page, the professor of ...
... Conseco, Inc. (NYSE:,CNO) will host a question and ... p.m. Eastern Daylight Time today. During the company,s long ... a service,provider prevented callers from accessing the Q & ... To access the conference call, dial (888) 251-7470 ...
... Sept. 27 The Patient,Advocate Foundation (PAF) -- ... tens of thousands of patients every year who,are ... financial or insurance,denials --announced this month the addition ... policy leaders and medical professionals ---,Roy Ramthun; Pearl ...
... leading cause of parasitic infections in U.S. , THURSDAY, ... genome of the intestinal parasite Giardia lamblia , ... in the United States. , That makes giardia the ... in the country, experts note. , People contract Giardia ...
... home team from the bleachers this fall, high school gridiron ... see anything out of the ordinary down on the field. ... the maroon helmets worn by the Unity High School Rockets, ... varsity team members are sporting helmets outfitted with the same ...
Cached Medicine News:
Bunell Mini-Modified Safety Finger Pin reduces PIP flexion contractures....
... for use with custom made splints to ... foam lining replaces fingernail hooks and sutures ... are truly the "No More Superglue®" splints. ... and boxes of 25. FoamWrap™ splints are ...
... causes of minor knee pain like arthritis, ... concert with the motion of the knee, ... patellar tendon and assisting in the relief ... support with high density foam padding molds ...
... The RCAI Active Neoprene Knee Brace provides ... athletic activities. The breathable airprene wrap provides ... bilateral metal hinges provide stability and protect ... allows full range of motion with a ...
Medicine Products:
(Date:2/19/2019)... ... , ... ExceleraRx Corporation announced today that St. Luke’s Health System has joined ... in the state of Idaho. , “We are very pleased to welcome ... ExceleraRx Corp. “We believe St. Luke’s commitment to expanding and leveraging its pharmacy capabilities ...
(Date:2/17/2019)... ... ... Wendy B. Libby, Ph.D., today announced her decision to retire as president of ... became Stetson’s ninth president in July 2009 and its first female president since the ... of an institution as fine as Stetson University,” Libby said in announcing her decision ...
(Date:2/16/2019)... Tenn. (PRWEB) , ... February 15, 2019 , ... ... market, has joined the esteemed Haute Beauty network. , The Haute Beauty Network, ... Dr. Bryant as a leading Face expert and our newest addition to ...
Breaking Medicine Technology:
... Mich., July 5, 2011 Allure Medical Spa released ... treatments and to help them visualize potential outcomes. "Many ... for the newest treatments," explains board certified cosmetic surgeon, ... a digital resource in the palm of their hands ...
... Spine, LLC, a medical device company focused on developing ... disc disease, today announced a 131% sales increase for ... and a 20% increase sequentially. These record results represent ... the company. RSB Spine Chief Executive Officer ...
Cached Medicine Technology: